iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

ZIM Laboratories announces grant of marketing authorization for 'Sildenafil 50 mg' in Spain, Europe

13 May 2022 , 11:27 AM

ZIM Laboratories Limited, a pharmaceutical company which manufactures differentiated generic products based on R&D and innovative process technologies has announced that AEPMS – The Spanish Agency for Medicine and Healthcare Products has granted Marketing Authorisation for it’s innovative product “Sildenafil 50 mg” ODS in Spain to it’s wholly owned European Subsidiary — SIA ZIM Laboratories Limited.

ZIM Labs is a pioneer in developing Oral Thin Films (“OTF”) an innovative and novel drug delivery dosage form. The above product is developed using patented Thinoral technology, which yields instantly wettable, rapidly dissolving, and stable orally dissolving films.

The conventional dosage form such as tablet and capsule are difficult to administer, may poses choking hazards and unfriendly to patient convenience. Against the odds of drug intake, oral thin film dissolves instantly after placing on the tongue and results in faster action. Unique features of OTFs and it’s flexibility offers unparalleled convenience in drug handling and administration.

According to various global research institutions, the market of sildenafil is expected to gain healthy growth in the forecast period of 2021 to 2028.Rising adoption of sedentary lifestyle and increasing incidence of lifestyle diseases are further anticipated to fuel the growth.

Dr. Anwar Daud, Chairman & Managing Director of ZIM Laboratories, gladly commented on the authorization, “The marketing approval for Sildenafil Oral Thin Films can be viewed as a further assurance that ZIM laboratories with it’s R&D capabilities and high quality manufacturing standards can become a promising partner for the overseas clients who look for the cost effective innovative drug delivery solutions to meet global market challenges and cater the needs of patients and medical professionals”.

At around 11:29 AM, ZIM Laboratories was trading flat at Rs190 per piece on the BSE.

Related Tags

  • launch
  • Pharma
  • ZIM Laboratories Limited
  • ZIM Laboratories Limited news
  • ZIM Laboratories Limited shares
  • ZIM Laboratories Limited stocks
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.